跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEFERASIROX SUN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DEFERASIROX SUN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DEFERASIROX SUN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sun Pharmaceutical Industries (Europe) B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 3, 2023
Approval ID
9cfe12d7a5275224
Company
Sun Pharmaceutical Industries (Europe) B.V.
Type
Standard
Approval Details
Approval Id
9cfe12d7a5275224
Drug Cima Aemps Name
DEFERASIROX SUN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89129
Holder Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/sun-pharmaceutical-industries-europe-b-v
Authorization Date
2023-11-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
180 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Company Detail Path
/organization/sun-pharmaceutical-industries-europe-b-v
Company Information
Pharmaceutical Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Country Name
Netherlands
City Name
hoofddorp,noord-holland,country_nl
Address
Polarisavenue 87
Active Ingredients
DEFERASIROX
180 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 3, 2023
Approval ID
9cfe12d7a5275224
Type
Standard
Back to CIMA-AEMPS Approvals